145 related articles for article (PubMed ID: 22963044)
1. Pretreatment of hepatocyte growth factor gene transfer mediated by octaarginine peptide-modified nanoparticles ameliorates LPS/D-galactosamine-induced hepatitis.
Hayashi Y; Mizuno R; Ikramy KA; Akita H; Harashima H
Nucleic Acid Ther; 2012 Oct; 22(5):360-3. PubMed ID: 22963044
[TBL] [Abstract][Full Text] [Related]
2. Octaarginine- and pH sensitive fusogenic peptide-modified nanoparticles for liver gene delivery.
Khalil IA; Hayashi Y; Mizuno R; Harashima H
J Control Release; 2011 Dec; 156(3):374-80. PubMed ID: 21864599
[TBL] [Abstract][Full Text] [Related]
3. Efficient short interference RNA delivery to tumor cells using a combination of octaarginine, GALA and tumor-specific, cleavable polyethylene glycol system.
Sakurai Y; Hatakeyama H; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
Biol Pharm Bull; 2009 May; 32(5):928-32. PubMed ID: 19420766
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid controls the uptake pathway and intracellular trafficking of an octaarginine-modified gene vector in CD44 positive- and CD44 negative-cells.
Yamada Y; Hashida M; Harashima H
Biomaterials; 2015 Jun; 52():189-98. PubMed ID: 25818425
[TBL] [Abstract][Full Text] [Related]
5. Enhanced gene expression by a novel stearylated INF7 peptide derivative through fusion independent endosomal escape.
El-Sayed A; Masuda T; Khalil I; Akita H; Harashima H
J Control Release; 2009 Sep; 138(2):160-7. PubMed ID: 19465073
[TBL] [Abstract][Full Text] [Related]
6. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation.
Akita H; Kogure K; Moriguchi R; Nakamura Y; Higashi T; Nakamura T; Serada S; Fujimoto M; Naka T; Futaki S; Harashima H
J Control Release; 2010 May; 143(3):311-7. PubMed ID: 20080139
[TBL] [Abstract][Full Text] [Related]
7. Octaarginine-modified multifunctional envelope-type nano device for siRNA.
Nakamura Y; Kogure K; Futaki S; Harashima H
J Control Release; 2007 Jun; 119(3):360-7. PubMed ID: 17478000
[TBL] [Abstract][Full Text] [Related]
8. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
[TBL] [Abstract][Full Text] [Related]
9. Comparison between a multifunctional envelope-type nano device and lipoplex for delivery to the liver.
Yamauchi J; Hayashi Y; Kajimoto K; Akita H; Harashima H
Biol Pharm Bull; 2010; 33(5):926-9. PubMed ID: 20460780
[TBL] [Abstract][Full Text] [Related]
10. Protective action of hepatocyte growth factor for acute liver injury caused by D-galactosamine in transgenic mice.
Okano J; Shiota G; Kawasaki H
Hepatology; 1997 Nov; 26(5):1241-9. PubMed ID: 9362368
[TBL] [Abstract][Full Text] [Related]
11. Costunolide protects lipopolysaccharide/d-galactosamine-induced acute liver injury in mice by inhibiting NF-κB signaling pathway.
Wang Y; Zhang X; Zhao L; Shi M; Wei Z; Yang Z; Guo C; Fu Y
J Surg Res; 2017 Dec; 220():40-45. PubMed ID: 29180209
[TBL] [Abstract][Full Text] [Related]
12. Influence of murine hepatitis induced by D-(+)-galactosamine hydrochloride and lipopolysaccharide on gene expression of polyethylenimine/plasmid DNA polyplex.
Miyanaga K; Yoshioka T; Nakagawa H; Kitahara T; To H; Ichikawa N; Nakashima M; Nishida K; Nakamura J; Sasaki H
Biol Pharm Bull; 2008 Aug; 31(8):1585-9. PubMed ID: 18670093
[TBL] [Abstract][Full Text] [Related]
13. Preventive effects of interleukin-6 in lipopolysaccharide/d-galactosamine induced acute liver injury via regulating inflammatory response in hepatic macrophages.
Li L; Duan C; Zhao Y; Zhang X; Yin H; Wang T; Huang C; Liu S; Yang S; Li X
Int Immunopharmacol; 2017 Oct; 51():99-106. PubMed ID: 28822324
[TBL] [Abstract][Full Text] [Related]
14. A DNA microarray-based analysis of immune-stimulatory and transcriptional responses of dendritic cells to KALA-modified nanoparticles.
Akita H; Ishii S; Miura N; Shaheen SM; Hayashi Y; Nakamura T; Kaji N; Baba Y; Harashima H
Biomaterials; 2013 Nov; 34(35):8979-90. PubMed ID: 23968857
[TBL] [Abstract][Full Text] [Related]
15. A multifunctional envelope-type nanodevice for use in nanomedicine: concept and applications.
Nakamura T; Akita H; Yamada Y; Hatakeyama H; Harashima H
Acc Chem Res; 2012 Jul; 45(7):1113-21. PubMed ID: 22324902
[TBL] [Abstract][Full Text] [Related]
16. Protective mechanisms of wogonoside against Lipopolysaccharide/D-galactosamine-induced acute liver injury in mice.
Gao YZ; Zhao LF; Ma J; Xue WH; Zhao H
Eur J Pharmacol; 2016 Jun; 780():8-15. PubMed ID: 26921756
[TBL] [Abstract][Full Text] [Related]
17. KALA-modified multi-layered nanoparticles as gene carriers for MHC class-I mediated antigen presentation for a DNA vaccine.
Shaheen SM; Akita H; Nakamura T; Takayama S; Futaki S; Yamashita A; Katoono R; Yui N; Harashima H
Biomaterials; 2011 Sep; 32(26):6342-50. PubMed ID: 21658761
[TBL] [Abstract][Full Text] [Related]
18. [Development of a novel artificial gene delivery system multifunctional envelope-type nano device for gene therapy].
Kogure K
Yakugaku Zasshi; 2007 Oct; 127(10):1685-91. PubMed ID: 17917425
[TBL] [Abstract][Full Text] [Related]
19. Improving in vivo hepatic transfection activity by controlling intracellular trafficking: the function of GALA and maltotriose.
Akita H; Masuda T; Nishio T; Niikura K; Ijiro K; Harashima H
Mol Pharm; 2011 Aug; 8(4):1436-42. PubMed ID: 21598999
[TBL] [Abstract][Full Text] [Related]
20. The transfection activity of R8-modified nanoparticles and siRNA condensation using pH sensitive stearylated-octahistidine.
Toriyabe N; Hayashi Y; Harashima H
Biomaterials; 2013 Jan; 34(4):1337-43. PubMed ID: 23141897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
